5 completed. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
Follow RNS60: new trials by email Literature Review of RNS60 trials Research Report on RNS60
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS) RNS60 - ALS | Phase 1 | Completed | Sabrina Paganoni, M.D. | 24 | 2015-10-01 | 2021-05-28 |
| Systemic Bioactivity of Inhaled Nebulized RNS60 RNS60, Normal saline - Systemic Bioactivity of Nebulized RNS60 | Phase 1 | Completed | Revalesio Corporation | 56 | 2015-07-01 | 2015-09-22 |
| Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma RNS60, Normal Saline, Budesonide - Asthma | Phase 1 | Completed | Revalesio Corporation | 65 | 2012-06-01 | 2014-07-28 |
| Safety and Tolerability of RNS60 Given by IV to Healthy Subjects RNS60, Placebo - Myocardial Infarct | Phase 1 | Completed | Revalesio Corporation | 12 | 2011-07-01 | 2011-10-04 |
| Safety Study of Nebulized RNS60 to Treat Asthma. RNS60, RNS60 - single dose - Asthma | Phase 1 | Completed | Revalesio Corporation | 36 | 2010-05-01 | 2012-01-12 |
Asthma (2) · Myocardial Infarction (1)
Revalesio Corporation (4) · Sabrina Paganoni, M.D. (1)
United States (4) · United Kingdom (1)
Kari C Nadeau, M.D., Ph.D. (1) · Kelly Craven, M.D. (1) · Nazem Atassi, MD (1) · Richard L Watson, M.D. (1) · Sabrina Paganoni, MD (1)